Prior studies on the comparison of endocrine toxicity spectrum between anti-CLTA-4 and anti-PD-1 showed that hypophysitis is closely related to anti-CTLA-4 monotherapy, and thyroid dysfunction is closely related to anti-PD-1 monotherapy [4, 30]. The gene discussed is CTLA4; the disease is hypophysitis.